SCHEMBL862853

SCHEMBL862853

CCOC(=O)NC(=S)Nc1nc(Cl)ncc1OC

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.39
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
KDR P35968 6/20 0.38
DPP4 P27487 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
EGFR P00533 4/20 0.37
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12067848 0.89 ALDH1A1 (0.43) MAPKAPK2MAPTKDM4EKMT2APKM
SCHEMBL1619616 0.88 MAPT (0.40) MAPKAPK2MAPTKDM4EKDRDPP4
SCHEMBL862918 0.87 MAPT (0.39) MAPKAPK2MAPTKDM4EKDRDPP4
SCHEMBL14300707 0.86 KMT2A (0.40) MAPTKDM4ECYP2C9KMT2APKM
SCHEMBL1621164 0.86 ALDH1A1 (0.38) KDM4EKDRDPP4CYP1A2CYP3A4
SCHEMBL862858 0.86 ALDH1A1 (0.38) KDM4EKDRDPP4CYP1A2CYP3A4
SCHEMBL1684000 0.86 KDR (0.38) KDM4EKDRDPP4CYP1A2CYP3A4
SCHEMBL18175977 0.86 KDR (0.38) MAPKAPK2MAPTKDM4EKDRDPP4
SCHEMBL7841063 0.83 MAPT (0.42) MAPTKDM4ESMN1; SMN2
SCHEMBL28801538 0.80 POLB (0.39) KDM4EKDRDPP4CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2851367-B1 PROCESS FOR THE PREPARATION OF A 2-AMINO-5,8-ALKOXY[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE BY REACTION OF A 5-HALO-8-ALKOXY[1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-2-AMINE WITH AN ALKALI METAL ALKOXIDE IN AN ALCOHOLIC SOLVENT DOW AGROSCIENCES LLC (US) 2016-10-26 EP disclosed
EP-2576558-B9 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-2-AMINES DOW AGROSCIENCES LLC (US) 2015-07-08 EP disclosed
EP-2851367-A1 Process for the preparation of a 2-amino-5,8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine by reaction of a 5-halo-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amine with an alkali metal alkoxide in an alcoholic solvent Dow AgroSciences LLC (US) 2015-03-25 EP disclosed
EP-2576558-B1 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-2-AMINES DOW AGROSCIENCES LLC (US) 2014-12-24 EP disclosed
US-8338596-B2 Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines DOW AGROSCIENCES LLC (US) 2012-12-25 US disclosed
US-8338596-B2 Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines DOW AGROSCIENCES LLC (US) 2012-12-25 US disclosed
US-20120088913-A1 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-2-AMINES DOW AGROSCIENCES LLC (US) 2012-04-12 US disclosed
US-20120088913-A1 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-2-AMINES DOW AGROSCIENCES LLC (US) 2012-04-12 US disclosed
US-8143395-B2 Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines DOW AGROSCIENCES LLC (US) 2012-03-27 US disclosed
US-8143395-B2 Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines DOW AGROSCIENCES LLC (US) 2012-03-27 US disclosed
US-20110295003-A1 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-2-AMINES DOW AGROSCIENCES LLC (US) 2011-12-01 US disclosed
US-20110295003-A1 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-2-AMINES DOW AGROSCIENCES LLC (US) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295003-A1 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-2-AMINES PAH, AZI2, ABL2 MAPKAPK2 1155/4885MAPT 2607/4885KDM4E 561/4885
US-20120088913-A1 PROCESS FOR THE PREPARATION OF 5-SUBSTITUTED-8-ALKOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-2-AMINES PAH, AZI2, ABL2 MAPKAPK2 1155/4885MAPT 2607/4885KDM4E 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.